All News

Found 20,576 articles

• Ortho-McNeil Pharmaceutical, Inc. To Co-Develop Bayer AG's Key Thrombosis Drug

  10/26/2005

• Tibotec Pharmaceuticals Ltd Announces U.S. Expanded Access Program For TMC114

  10/26/2005

• Boston Scientific Corporation Release: TAXUS(R) Stent Demonstrates Excellent Efficacy And Safety In Independent "STENT" Registry

  10/26/2005

• Announces Release Of Cedara I-ReadMammo(TM) Digital Mammograhy Workstation Software

  10/26/2005

• Matrixx Initiatives, Inc. Reports 49% Revenue Growth In The Third Quarter And A 53% Increase In Net Income

  10/26/2005

• Vion Pharmaceuticals To Present At C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference

  10/26/2005

• Serono International S.A. Signs Cancer Drug Deal With Rigel Pharmaceuticals, Inc., Eyes More

  10/25/2005

• Johnson & Johnson To Buy Rembrandt From Procter & Gamble

  10/25/2005

• Vion Pharmaceuticals Holds Annual Meeting And Provides Clinical And Preclinical Development Update

  10/25/2005

• Centocor, Inc. Release: REMICADE Data Show Promise For Children Afflicted With Crohn's Disease

  10/25/2005

• Palomar Medical Technologies Awarded Additional Funding And Contract Extension From US Army Medical Department

  10/25/2005

• Immunicon Corporation To Report Third Quarter 2005 Financial Results On November 1, 2005

  10/25/2005

• Obagi Medical Products, Inc. Announces CEO And Key Management Appointments

  10/24/2005

• Alan West Joins The Pittsburgh Life Sciences Greenhouse As An Executive-In-Residence

  10/24/2005

• Inlet Medical, Inc. Ranks On Both The Inc. 500 And The Business Journal Growth 50 Lists Of Fastest-Growing Private Companies

  10/24/2005

• ev3 Inc. And Micro Therapeutics, Inc. To Report 2005 Third-Quarter Financial Results And Host Joint Conference

  10/21/2005

• West Pharmaceutical Services Elects Paula A. Johnson, M.D., MPH, To Board Of Directors

  10/21/2005

• Cleveland Clinic Foundation To Host 2005 Medical Innovation Summit Oct. 24-26

  10/21/2005

• Arbios Systems Appoints Walter C. Ogier Chief Executive Officer

  10/20/2005

• Cordis Corporation The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms The Taxus Stent In Analysis Of Seven Clinical Trials

  10/20/2005